About Avicenna Biosciences
Avicenna Biosciences is a company based in Durham (United States) founded in 2020. Avicenna Biosciences has raised $5.5 million across 3 funding rounds.
- Headquarter Durham, United States
- SectorsTechnology
- Phone•••• ••••
- Total Equity Funding$5.5M (USD)
in 3 rounds
- Latest Funding Round$6M (USD), Debt – Conventional
Nov 2023
Funding Insights of Avicenna Biosciences
Avicenna Biosciences has successfully raised a total of $5.5M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $6 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.5M
- Total Rounds 3
- Last Round Debt – Conventional — $6M
- First Round $2.5M
(Sep 2020)
All 3 funding rounds of Avicenna Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $6M | Debt – Conventional | – | – | – |
| Dec 2022 | $3M | Series A | – | – | – |
| Sep 2020 | $2.5M | Series A | – | – | – |
People of Avicenna Biosciences
3 people are tracked at Avicenna Biosciences (3 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Kaiser | CEO | Leadership |
Pieter Burger | CEO | Leadership |
Christopher Meldrum | CEO | Leadership |
Complete people profiles for Avicenna Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avicenna Biosciences
3 dated milestones of Avicenna Biosciences across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Avicenna Biosciences is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Debt – Conventional, of $6.0M.
Similar companies to Avicenna Biosciences
10 companies that operate in the same segment as Avicenna Biosciences (AI in Life Sciences), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provides AI solutions and services for research publishing and communication. | 2001 | Mumbai, Maharashtra, India | – | USD 91.43 M | 1,025 | |
High-performance computing research is conducted by BSC in Barcelona. | 2005 | Barcelona, Catalonia, Spain | – | – | – | |
Scientific communications, localization, and AI services for researchers and publishers. | 2000 | Mumbai, Maharashtra, India | – | USD 25.46 M | 243 | |
Fullpower-AI is recognized as a leading AI-biosensing platform company. | 2003 | Santa Cruz, California, United States | USD 25 M | – | – | |
Provides big data analytics solutions tailored for the life sciences sector. | 2006 | Bengaluru, Karnataka, India | – | – | – | |
AI-powered drug intelligence platform for life science professionals | – | Beijing, China | – | – | – | |
Resource and marketplace for lab tools, services, and research news. | 2013 | Bengaluru, Karnataka, India | – | – | – | |
Live cell imaging solutions are delivered via an AI-based platform. | – | Wilmington, Delaware, United States | – | – | – | |
PR agency offering AI-assisted communications and media services for biotech companies. | 2023 | Singapore, Singapore | – | – | – | |
Synthetic peptide drugs are developed via an AI platform. | 2022 | Beijing, China | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avicenna Biosciences
Avicenna Biosciences was founded in 2020.
Avicenna Biosciences is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Thomas Kaiser is the current CEO of Avicenna Biosciences.
Avicenna Biosciences is a funded company, having raised a total of $5.5M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Sep 2020.
Avicenna Biosciences was founded in 2020 and is based in Durham, United States. Operations focus on the biotechnology sector, where small molecule drug candidates are optimized through machine learning-enhanced medicinal chemistry. This approach is applied to accelerate the drug development process. Services target improvements in efficiency for pharmaceutical research and development.